Pathogenesis of Liver Fibrosis
The DOI matches its Crossref record; 220 of the 222 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
Liver fibrosis is a major cause of morbidity and mortality worldwide due to chronic viral hepatitis and, more recently, from fatty liver disease associated with obesity. Hepatic stellate cell activation represents a critical event in fibrosis because these cells become the primary source of extracellular matrix in liver upon injury. Use of cell-culture and animal models has expanded our understanding of the mechanisms underlying stellate cell activation and has shed new light on genetic regulation, the contribution of immune signaling, and the potential reversibility of the disease. As pathways of fibrogenesis are increasingly clarified, the key challenge will be translating new advances into the development of antifibrotic therapies for patients with chronic liver disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“STAT3, a member of the STATs family, is a key transcriptional mediator of cellular processes [43, 44].”
From Saikosaponin b1 Attenuates Liver Fibrosis by Blocking STAT3/Gli1 Interaction and Inducing Gli1 Degradation (2025) · cites this paper as [43]
In the citing paper
“they may also derive from portal fibroblasts, bone marrow-derived cells, circulating fibrocytes, [7] and by the controversially discussed epithelial-tomesenchymal (EMT) [8,9] or endothelial-to-mesenchymal (EndoTM) transition.[10,11]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [7]
Citations
Cites
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Origins and Mechanisms of miRNAs and siRNAs
Carthew, R. W., & Sontheimer, E. J. (2009) · Cell · doi:10.1016/j.cell.2009.01.035 · Cited by 5,018
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Self-citationMany roads to maturity: microRNA biogenesis pathways and their regulation
Winter, J., Jung, S., Keller, S., Gregory, R. I., & Diederichs, S. (2009) · Nature Cell Biology · doi:10.1038/ncb0309-228 · Cited by 2,656
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Self-citationEndothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Bendelac, A., Savage, P. B., & Teyton, L. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141711 · Cited by 2,155
Research works printed but not linked: 15
- 10.1172/jci200112373 · DOI · Paper page
- 10.1055/s-2001-17556 · DOI · Paper page
- Stupack DG., 2007, Oncology, 21, 6
- Hehlgans S, 2007, Biochim. Biophys. Acta, 1775, 163
- Omenetti A, 2008, J. Clin. Investig., 118, 3331
- Pinzani M, 1996, Am. J. Pathol., 148, 785
- Sims DE., 1991, Can. J. Cardiol., 7, 431
- Thimgan MS, 1999, Am. J. Physiol., 277, G137
- 10.1136/gut.2005.088690 · DOI · Paper page
- Gao B., 2005, Cell Mol. Immunol., 2, 92
- Anania FA, 1995, Hepatology, 21, 1640
- Connolly MK, 2009, J. Clin. Investig., 119, 3213
- Seki E, 2009, J. Clin. Investig., 119, 1858
- McCrudden R, 2000, Histol. Histopathol., 15, 1159
- 10.1002/hep.23046 · DOI · Paper page
Cited by
Items 901–1,000 of 1,007
Vitamin D3 supplementation alleviates chemically-induced cirrhosis-associated hepatocarcinogenesis
Goto, R. L., Tablas, M. B., Prata, G. B., Santo, S. G. E., Fernandes, A. A. H., Cogliati, B., Barbisan, L. F., & Romualdo, G. R. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.106022 · Cited by 20
Lee, C., Han, J., & Jung, Y. (2022) · Biology · doi:10.3390/biology11050637 · Cited by 20
“When the liver is severely and/or chronically injured, massive hepatocyte death occurs, which is accompanied by inflammation and fibrosis [4,5].”
BackgroundProcyanidin B2 Attenuates Nicotine-Induced Hepatocyte Pyroptosis through a PPARγ-Dependent Mechanism
Liu, J., Yao, Q., Xie, X., Cui, Q., Jiang, T., Zhao, Z., Du, X., Lai, B., Xiao, L., & Wang, N. (2022) · Nutrients · doi:10.3390/nu14091756 · Cited by 20
“Both acute and chronic liver injury may induce wound-healing response, leading to the formation of hepatic fibrosis even hepatic carcinoma [39].”
BackgroundRare earth cerium oxide nanoparticles attenuated liver fibrosis in bile duct ligation mice model
Godugu, C., Khurana, A., & Saifi, M. A. (2022) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2022.127102 · Cited by 20
Biomarkers of liver fibrosis detecting with electrochemical immunosensor on clinical serum
Yao, Y., Bao, J., Lu, Y., Zhang, D., Luo, S., Cheng, X., Zhang, Q. Y., Li, S., & Liu, Q. (2015) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2015.08.064 · Cited by 20
Cellular and molecular mechanisms of hepatic fibrogenesis leading to liver cancer
Minicis, S. D., Marzioni, M., Saccomanno, S., Rychlicki, C., Agostinelli, L., Trozzi, L., Benedetti, A., & Svegliati‐Baroni, G. (2011) · Translational gastrointestinal cancer · Cited by 21
Givinostat inhibition of hepatic stellate cell proliferation and protein acetylation
Wang, Y., Xu, L., Wang, T., Wei, J., Meng, W.-Y., Wang, N., & Shi, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i27.8326 · Cited by 20
GATA binding protein 3 is correlated with leptin regulation of PPAR γ1 in hepatic stellate cells
Guan, W., Cheng, F., Wu, H., Cao, Q., Zhu, X., Fan, Y., Zhu, H., & Zhou, Y. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13002 · Cited by 20
Elias, M. D. B., de Oliveira, F. L., Guma, F. T. C. R., Martucci, R. B., Borojević, R., & Teodoro, A. J. (2019) · Food & Function · doi:10.1039/c8fo02369g · Cited by 20
Communication initiated by hepatocytes: The driver of HSC activation and liver fibrosis
Lan, R., Lin, J., Chen, S., Lü, Z., Gong, Y., Tan, S., Liu, X., & He, W. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000753 · Cited by 19
Xiong, Y., Wen, S., Li, Y., Wei, Y., Fang, B., Li, C., Huang, Q., & Lin, X. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174770 · Cited by 19
TRPM8 deficiency attenuates liver fibrosis through S100A9-HNF4α signaling
Liu, Q., Lei, X., Cao, Z., Zhang, J., Yan, L., Fu, J., Tong, Q., Qin, W., Shao, Y., Liu, C., et al. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00789-4 · Cited by 19
“Introduction Liver fibrosis, a major health care burden worldwide, represents the ubiquitous response of the liver to almost all chronic injuries predominantly arising from sustained viral infection, excessive alcohol consumption, metabolic etiologies, and autoimmune liver diseases [1, 2].”
BackgroundDing, S., Jiang, J., Zhang, G., Yu, M., & Zheng, Y. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.114897 · Cited by 19
Liu, H., Wang, X., Deng, H., Huang, H., Liu, Y., Zhong, Z., Shen, L., Cao, S., Ma, X., Zhou, Z., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216086 · Cited by 19
Pydyn, N., Ferenc, A., Trzos, K., Pośpiech, E., Wilamowski, M., Mucha, O., Major, P., Kadłuczka, J., Rodrigues, P. M., Bañales, J. M., et al. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.01.021 · Cited by 19
The role and mechanism of hydrogen sulfide in liver fibrosis
Mao, S., Wang, X., Li, M., Liu, H., & Liang, H. (2024) · Nitric Oxide · doi:10.1016/j.niox.2024.02.002 · Cited by 19
A role for curcumin in preventing liver fibrosis in animals: a systematic review and meta-analysis
Huang, B.-H., Guo, Z., Lv, B., Zhao, X., Li, Y., & Lv, W. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1396834 · Cited by 19
Liu, H., Huang, H., Liu, Y., Yang, Y., Deng, H., Wang, X., Zhou, Z., Peng, G., Jin, S., Chen, D., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03988-7 · Cited by 19
“The activation of hepatic stellate cells (HSCs) by fibrogenic mediators and cytokines is a crucial aspect of the liver fibrosis process [5, 6].”
BackgroundBML-111 equilibrated ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis to protect hepatic fibrosis in rats
Hu, Q.-D., Hu, Z., Chen, Q., Huang, Y., Mao, Z., Xu, F., & Zhou, X. (2017) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2017.08.008 · Cited by 19
Rizk, F. H., Sarhan, N. I., Soliman, N. A., Ibrahim, M. A., Abd-Elsalam, M. M., & Abd-Elsalam, S. M. (2018) · IUBMB Life · doi:10.1002/iub.1884 · Cited by 19
“HSCs are the main extracellular matrix (ECM) producing cells in cases of liver damage (3).”
BackgroundHe, S., Tang, J. Y., Diao, N., Liao, Y., Shi, J., Xu, X., Xie, F., & Bai, L. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1615931 · Cited by 19
“entiation of HSCs into myofibroblast-like cells [6].”
PET/SPECT Molecular Probes for the Diagnosis and Staging of Nonalcoholic Fatty Liver Disease
Shao, T., Josephson, L., & Liang, S. H. (2019) · Molecular Imaging · doi:10.1177/1536012119871455 · Cited by 19
“Although the molecular pathways that lead to the pathogenesis and process of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH; a progressive form of NAFLD) remain poorly understood, it is accepted that inflammation, accumulation of extracellular matrix proteins, and proliferation of myof…”
BackgroundNithyananthan, S., & Thirunavukkarasu, C. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114760 · Cited by 19
Zehra, M., Curry, J. C., Pillai, S. S., Lakhani, H. V., Edwards, C. E., & Sodhi, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134737 · Cited by 19
Wang, Z., Cheng, Z., Abrams, S. T., Lin, Z., Yates, E. A., Yu, Q., Yu, W., Chen, P., Toh, C., & Wang, G. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i47.7513 · Cited by 19
G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases
Li, N., Shan, S., Li, X., Chen, T., Meng, Q., Zhang, S., Wang, Z., Zhang, L., Wei, W., & Sun, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.822345 · Cited by 19
“Liver fibrosis may develop into cirrhosis, even ultimately leading to hepatocellular carcinoma (100).”
BackgroundSafran, M., Masoud, R., Sultan, M., Tachlytski, I., Gadot, C. C., Pery, R., Balint‐Lahat, N., Pappo, O., Buzaglo, N., & Ben‐Ari, Z. (2022) · Cells · doi:10.3390/cells11101715 · Cited by 19
“Chronic liver diseases (CLDs), such as alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD/NASH), and chronic viral hepatitis, can progress to the development of liver fibrosis (LF) [1,2].”
Backgroundvan Son, K. C., Verschuren, L., Hanemaaijer, R., Reeves, H. L., Takkenberg, R. B., Drenth, J. P. H., Tushuizen, M. E., & Holleboom, A. G. (2023) · Cancers · doi:10.3390/cancers15041308 · Cited by 19
Marfà, S., Crespo, G., Reichenbach, V., Forns, X., Casals, G., Morales‐Ruiz, M., Navasa, M., & Jiménez, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109254 · Cited by 19
Yang, C., CUI, F., CHEN, L. M., Gong, X., & Qin, B. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4618 · Cited by 19
Huang, S.-C., Kuo, P., Hung, H., Pan, T., Chen, F., & Wu, T.-S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050681 · Cited by 19
Doyle, M.-A., Singer, J., Lee, T., Muir, M., & Cooper, C. (2016) · Trials · doi:10.1186/s13063-016-1454-6 · Cited by 20
Liu, Y., Li, L., Liu, J., She, W., Shi, J., Li, J., Wang, J., & Jiang, W. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.08.001 · Cited by 19
Thioacetamide-induced hepatic fibrosis in the common marmoset
Inoue, T., Ishizaka, Y., Sasaki, E., Lu, J., Mineshige, T., Yanase, M., Sasaki, E., & Shimoda, M. (2018) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.17-0156 · Cited by 19
Yang, G., Zhan, J., Yang, Y., Yuan, L., Wang, P., Ho, C., & Li, S. (2020) · Food Science and Human Wellness · doi:10.1016/j.fshw.2020.08.007 · Cited by 19
Curcumin regulates delta-like homolog 1 expression in activated hepatic stellate cell
Qiu, J., Zhou, Q., Zhai, X., Jia, X., & Zhou, Y. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.074 · Cited by 19
The protective effect of vitamin D against carbon tetrachloride damage to the rat liver
Özerkan, D., Özsoy, N., Akbulut, K., Güney, Ş., & Öztürk, G. (2017) · Biotechnic & Histochemistry · doi:10.1080/10520295.2017.1361549 · Cited by 19
Hepatic Stellate Cells Functional Heterogeneity in Liver Cancer
Sererols-Viñas, L., Garcia‐Vicién, G., Ruiz-Blázquez, P., Lee, T., Lee, Y. A., Gonzalez‐Sanchez, E., Vaquero, J., Moles, A., Filliol, A. A., & Affò, S. (2025) · Seminars in Liver Disease · doi:10.1055/a-2551-0724 · Cited by 18
Qiu, T. H., Zhu, X., Wu, J., Hong, W., Hu, W., & Fang, T. (2025) · Scientific Reports · doi:10.1038/s41598-025-92282-4 · Cited by 18
“Liver fibrosis is the hepatic repair response to chronic injury 51,52 .”
Miryan, M., Azizi, A., Pasdar, Y., & Moradi, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-02613-8 · Cited by 18
“Lower FIB-4 scores in individuals adhering to plant-based diets may reflect decreased hepatic stellate cell activation and collagen deposition, hallmarks of fibrogenesis 40,41 .”
Ferroptosis in liver fibrosis and its potential intervention strategy
Zhu, W., Fu, L., Cui, Y., Tang, Y., Liu, K., Shi, L., Gao, Y., Li, M., & Huang, L. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-10111-w · Cited by 18
“Ferroptotic hepatocytes can activate HSCs, which mediates the development of liver fibrosis (Hernandez-Gea and Friedman 2011).”
Hypoxia-induced factor and its role in liver fibrosis
Omar, J. M., Hai, Y., & Jin, S. (2022) · PeerJ · doi:10.7717/peerj.14299 · Cited by 18
Qin, L., Tan, J., Lv, X., & Zhang, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115673 · Cited by 18
Wang, H., Chang, Y., Liu, X., Liu, L., Hua, M., & Li, A. (2023) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14386 · Cited by 18
The role of Sirtuin 2 in liver - An extensive and complex biological process
Li, S., & Guo, L. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122431 · Cited by 18
Advances in Noninvasive Molecular Imaging Probes for Liver Fibrosis Diagnosis
Chen, S., Zhuang, D., Jia, Q., Guo, B., & Hu, G. (2024) · Biomaterials Research · doi:10.34133/bmr.0042 · Cited by 18
Xiao, B., Yang, W., Dong, H., Liu, T., Li, C., Wang, Y., Gao, D., Han, G., Kiran, F., Wang, A., et al. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c08790 · Cited by 18
Clinical Advances in Fibrosis Progression of Chronic Hepatitis B and C
Wu, Y.-J., Xu, M., & Lu, L. (2014) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2014.00029 · Cited by 18
Cell Therapy in Chronic Liver Disease
Alhomrani, M., Lim, R., & Sievert, W. (2016) · Stem cells in clinical applications · doi:10.1007/978-3-319-46693-4_2 · Cited by 18
Liu, H., Chen, Z., Jin, W., Barve, A. J., Wan, Y. Y., & Cheng, K. (2017) · Liver Research · doi:10.1016/j.livres.2017.05.003 · Cited by 18
de Vaca, R. P., Domínguez, M., Guerrero‐Celis, N., Rodríguez‐Aguilera, J. R., & de Sánchez, V. C. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.10.019 · Cited by 18
Lestari, N., Louisa, M., Soetikno, V., Suwana, A. G., Ramadhan, P. A., Akmal, T., & Arozal, W. (2018) · Journal of Toxicology · doi:10.1155/2018/5360496 · Cited by 18
“In normal liver, HSC is a quiescent and serves as a retinoid deposit that will differentiate into myofibroblasts when activated [4, 5].”
BackgroundQi, Y., Pan, L., Qi, S., Liu, F., Wang, Z., Qian, C., Chen, L., & Du, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.634902 · Cited by 18
Natarajan, V., Moeun, Y., & Kidambi, S. (2021) · Biology · doi:10.3390/biology10050408 · Cited by 18
lncRNA MEG3 modulates hepatic stellate cell activation by sponging miR‑145 to regulate PPARγ
Qin, R., Huang, W., Huang, Y., Zhang, Z., Su, Y., Chen, S., & Wang, H. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12519 · Cited by 18
Computational simulation of liver fibrosis dynamics
Yoshizawa, M., Sugimoto, M., Tanaka, M., Sakai, Y., & Nishikawa, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-18123-w · Cited by 18
MicroRNA-370 Attenuates Hepatic Fibrogenesis by Targeting Smoothened
Lu, C., Hou, Q.-R., Deng, L.-F., Fei, C., Xu, W., Zhang, Q., Wu, K., Ning, B., Xie, W., & Zhang, X. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3585-0 · Cited by 18
Inhibitory effects of capsaicin on hepatic stellate cells and liver fibrosis
Yu, F., Teng, Y., Zhu, Q., Zhang, Q., & Tang, Y. (2014) · Biochemistry and Cell Biology · doi:10.1139/bcb-2014-0036 · Cited by 18
“(HSCs) (Hernandez-Gea and Friedman 2011), which proliferate or become activated to transdifferentiate into myofibroblast-like cells.”
BackgroundStokkeland, K., Lageborn, C. T., Ekbom, A., Höijer, J., Bottai, M., Stal, P. I., & Söderberg, K. C. (2017) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12844 · Cited by 18
Xuan, J., Chen, Y., Zhu, L., Guo, Y., Deng, L., Zheng, Y., Wang, Z., Wang, Z., & Ao, M. (2017) · Oncotarget · doi:10.18632/oncotarget.21358 · Cited by 18
Cao, Q., Zhu, X., Zhai, X., Li, J., Cheng, F., Zhu, Y., Yu, P., & Zhou, Y. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.12.007 · Cited by 18
Lee, D.-Y., Yun, S., Song, M.-Y., Ji, S.-D., Son, J.-G., & Kim, E. (2020) · Cells · doi:10.3390/cells9030568 · Cited by 19
“Progression of disease with sustained fibrosis leads to cirrhosis, which may develop hepatocellular carcinoma (HCC) [2,7].”
BackgroundInfluentialA lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis modulates hepatic stellate cell (HSC) activation
Liao, J., Zhang, Z., Yuan, Q., Liu, Q., Kuang, J. C., Yuan, F., & Hu, X. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.10.001 · Cited by 18
Serotonin: A key molecule in acute and chronic liver injury!
Lesurtel, M., & Clavien, P. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2012.05.005 · Cited by 18
P311 modulates hepatic stellate cells migration
Guimarães, E. L. M., Stradiot, L., Mannaerts, I., Schroyen, B., & van Grunsven, L. A. (2014) · Liver International · doi:10.1111/liv.12691 · Cited by 18
Zhou, L., Shi, M., Zhao, L., Lin, Z., Tang, Z., Sun, H., Chen, T., Lv, Z., Xu, J., Huang, Y., et al. (2017) · Parasites & Vectors · doi:10.1186/s13071-017-2228-z · Cited by 18
Petrescu, A. D., Grant, S. M., Frampton, G. A., McMillin, M., Kain, J., Kodali, M., Shetty, A. K., & DeMorrow, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-31599-9 · Cited by 18
Li, W., Chen, J. Y., Sun, C., Sparks, R. P., Pantano, L., Rahman, R., Moran, S. P., Pondick, J. V., Kirchner, R., Wrobel, D., et al. (2022) · eLife · doi:10.7554/elife.74513 · Cited by 17
Activating Protein-1 (AP-1): A Promising Target for the Treatment of Fibrotic Diseases
Pi, Z., Qiu, X., Liu, J., Shi, Y., Zeng, Z., & Xiao, R. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230209100059 · Cited by 17
Zhang, N., Guo, F., & Song, Y. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.04.011 · Cited by 17
Shi, H., Duan, X., Dong, J., Tao, Y., & Yang, L. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117963 · Cited by 17
Exploring the Impact of Different Inflammatory Cytokines on Hepatitis C Virus Infection
Din, N. G. B. E., & Farouk, S. (2024) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2024.0003 · Cited by 17
Xie, Y., Li, X., Xu, L., Zhang, C., Ren, Y., Shi, X., Fu, L., Wang, J., Xu, X., Liu, Y., et al. (2024) · Materials Chemistry Frontiers · doi:10.1039/d4qm00532e · Cited by 17
Sferra, R., Vetuschi, A., Pompili, S., Gaudio, E., Speca, S., & Latella, G. (2016) · Pathology - Research and Practice · doi:10.1016/j.prp.2016.11.004 · Cited by 17
Ciceu, A., Baltă, C., Herman, H., Gharbia, S., Ignat, S.-R., Dinescu, S., Váradi, J., Fenyvesi, F., Gyöngyösi, S., Hermenean, A. O., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041869 · Cited by 17
Roles and distribution of telocytes in tissue organization in health and disease
Condrat, C. E., Barbu, M. G., Thompson, D. C., Dănilă, C. A., Boboc, A. E., Suciu, N., Crețoiu, D., & Voinea, S. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818561-2.00001-1 · Cited by 17
Perfluorooctane sulfonate aggravates CCl4 ‐induced hepatic fibrosis via HMGB1 / TLR4 /Smad signaling
Wan, C., Gu, T., Ling, J., Qin, Y., Luo, J., Sun, L., Hua, L., Zhao, J., & Jiang, S. (2022) · Environmental Toxicology · doi:10.1002/tox.23458 · Cited by 17
“occur, ECM and scar tissue will gradually replace the liver parenchyma and eventually form fibrosis.(42) Liver damage and”
BackgroundZhang, B., Wu, F., Li, P., & Li, H. (2022) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2022.2128369 · Cited by 17
“An estimated 887,000 deaths occur annually because of hepatitis B and related illnesses, which are mainly related to/associated with complications of cirrhosis and hepatocellular carcinoma (HCC) [2].”
BackgroundLiu, L.-Z., Wei, Y., Xie, N., Cai, H., & Lin, Y. (2024) · Cellular and Molecular Biology · doi:10.14715/cmb/2024.70.2.25 · Cited by 17
Wijesundera, K. K., Izawa, T., Tennakoon, A. H., Golbar, H. M., Tanaka, M., Kuwamura, M., & Yamate, J. (2015) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2015.05.002 · Cited by 17
“Persistent liver injury is associated with progressive fibrosis, cirrhosis, and ultimately hepatocellular carcinoma (HCC) (Bedossa and Paradis, 2003; Hernandez-Gea and Friedman, 2011; Zhang and Friedman, 2012).”
BackgroundDessein, A. J. J., Arnaud, V., He, H., Li, J., Dessein, H., Hou, X., Luo, X., & Li, Y. S. (2013) · Pathologie Biologie · doi:10.1016/j.patbio.2013.01.005 · Cited by 17
RAP-8 ameliorates liver fibrosis by modulating cell cycle and oxidative stress
Xu, H., Hong, S., Yan, Z., Zhao, Q., Shi, Y., Song, N., Xie, J., & Jiang, X. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.04.037 · Cited by 17
Gao, W., Sun, J. F., Wang, F., Lu, Y., Wen, C., Bian, Q., & Wu, H. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.07.015 · Cited by 17
Soydemir, S., Comella, O., Abdelmottaleb, D. I., & Pritchett, J. P. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2019.00312 · Cited by 17
“Mechanical force across a tissue can change due to fluctuations in blood pressure, the behavior of contractile cells (e.g., HSCs) and changes in the ECM.”
BackgroundInfluentialYin, X., Xue, S., Ji, J., Zhao, M., Shao, M., Yin, L., Zhang, S., Liu, L., Ли, Б., Zhang, L., et al. (2025) · Advanced Composites and Hybrid Materials · doi:10.1007/s42114-025-01411-0 · Cited by 16
“LF is generally considered a protective response to sustained liver injury and represents a shared pathological hallmark of most chronic liver diseases [4, 5].”
Expression of Syndecan-1 in Chronic Liver Diseases: Correlation With Hepatic Fibrosis
Charchanti, A. V., Kanavaros, P., Koniaris, E., Kataki, A., Glantzounis, G. K., Agnantis, N. J., & GOUSSIA, A. C. (2021) · In Vivo · doi:10.21873/invivo.12264 · Cited by 16
Shan, S., Liu, Z. Q., Wang, S., Liu, Z., Chao, S., Zhang, C., Li, M., & Song, F. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115409 · Cited by 16
Li, Q., Huang, D., Liao, W., Su, X., Li, J., Zhang, J., Fang, M., & Liu, Y. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23648 · Cited by 16
Liu, X., Zhang, W., Ma, B.-F., Sun, M., & Shang, Q.-H. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s467480 · Cited by 16
“The above studies suggest that inhibiting HSCs autophagy may reduce the degradation of LDs and induce lipid accumulation, thus attenuating the activation of HSCs, which may be an effective way to prevent and control HF.”
BackgroundInfluentialYao, H., He, Q., Li, X., Liu, S., Yang, Z., Li, X., Li, X., Huang, C., Wang, B., Xie, Q., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118593 · Cited by 16
Immune Checkpoints and the Immunology of Liver Fibrosis
Tsomidis, I., Voumvouraki, A., & Kouroumalis, E. (2025) · Livers · doi:10.3390/livers5010005 · Cited by 17
Atallah, M. A. A., Elaidy, S. M., & Tawfik, M. K. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.11.017 · Cited by 16
Jiang, Y., Han, X., Dou, J.-Y., Yuan, M.-H., Zhou, M.-J., Cui, Z., Lian, L., Nan, J., Zhang, X., & Wu, Y. (2022) · Food & Function · doi:10.1039/d1fo04404d · Cited by 16
Bai, L., Wang, Y., Chen, Y., Li, H., Zhu, S., Liu, Y., Song, Z., & Duan, S. (2022) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13682 · Cited by 16
Geervliet, E., Karkdijk, E., & Bansal, R. (2024) · Scientific Reports · doi:10.1038/s41598-024-67926-6 · Cited by 15
Muthiah, M. D., Huang, D. Q., Zhou, L., Jumat, N. H., Choolani, M., Chan, J. K. Y., Wee, A., Lim, S. G., & Dan, Y.-Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-51189-7 · Cited by 15
Chen, L., Huang, Y., Zhang, N., Qu, J., Fang, Y., Fu, J., Yuan, Y., Zhang, Q., Li, H., Wen, Z., et al. (2024) · MedComm · doi:10.1002/mco2.654 · Cited by 15
“…liver damage, the excessive accumulation of the extracellular matrix (ECM) causes liver fibrosis and physiological and pathological changes, 6,7 including the recruitment of various inflammatory and immune cells, barrier damage to liver sinusoidal endothelial cells (LSECs), activation of…”
BackgroundCollagen-targeted molecular imaging in diffuse liver diseases
Zhou, I. Y., Tanabe, K. K., Fuchs, B. C., & Caravan, P. (2020) · Abdominal Radiology · doi:10.1007/s00261-020-02677-2 · Cited by 14
“A characteristic feature of the fibrotic microenvironment associated with CLD is excessive deposition of extracellular matrix (ECM) proteins [22].”
BackgroundThe role of matrix metalloproteinases in liver function and disease
Mitropoulou, G., Kompoura, V., Saffioti, F., & Mavroeidis, V. K. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl27127 · Cited by 14
Huang, T., Zhou, M.-Y., Zou, G.-L., Hu, R.-H., Han, L., Zhang, Q.-X., & Zhao, X.-K. (2025) · Scientific Reports · doi:10.1038/s41598-025-88538-8 · Cited by 14
Metadata
- Authors
- Hernandez-Gea, V., & Friedman, S. L.
- Affiliations
- Division of Liver Diseases, Mount Sinai School of Medicine, New York, New York 10029;
- Icahn School of Medicine at Mount Sinai (US)
- ORCID
- Friedman, Scott L.
- Venue
- Annual Review of Pathology: Mechanisms of Disease
- Publisher
- Annual Reviews
- Published
- 2011-02-28
- Volume
- 6
- Issue
- 1
- Pages
- 425-456
- ISSN
- 1553-4006 (ISSN-L)
- 1553-4014
- OpenAlex
- W2142988890
- Cited by
- 1,809
- References
- 220
- Citations by year
- 2026: 81 · 2025: 123 · 2024: 121 · 2023: 112 · 2022: 148 · 2021: 174 · 2020: 145 · 2019: 119 · 2018: 117 · 2017: 131 · 2016: 136 · 2015: 124 · 2014: 97 · 2013: 76 · 2012: 67
- FWCI
- 10.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Pathology Mechanisms of Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- liver fibrosis, hepatic stellate cell activation, extracellular matrix, chronic viral hepatitis, hepatic steatosis, obesity, immune signaling, genetic control, fibrosis reversibility, antifibrotic therapy, chronic liver disease
- MeSH terms
- Humans, Liver, Liver Cirrhosis, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.